Aviva
AGN

Aviva’s Allergan plc AGN Stock Holding History

Aviva’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-206,322
Closed -$36.5M – 973
2020
Q1 		$36.5M Sell
206,322
-6,812
-3% -$1.28M 0.27% 79
2019
Q4 		$40.7M Buy
213,134
+3,728
+2% +$673K 0.25% 91
2019
Q3 		$35.2M Sell
209,406
-28,810
-12% -$4.69M 0.24% 96
2019
Q2 		$39.9M Sell
238,216
-5,717
-2% -$792K 0.27% 81
2019
Q1 		$35.7M Buy
243,933
+174
+0.1% +$25.2K 0.24% 98
2018
Q4 		$32.6M Sell
243,759
-34,952
-13% -$5.73M 0.24% 101
2018
Q3 		$53.1M Sell
278,711
-9,235
-3% -$1.7M 0.29% 91
2018
Q2 		$48M Sell
287,946
-6,078
-2% -$976K 0.28% 89
2018
Q1 		$49.5M Sell
294,024
-25,202
-8% -$4.23M 0.3% 89
2017
Q4 		$52.2M Buy
319,226
+23,928
+8% +$4.29M 0.3% 84
2017
Q3 		$60.5M Buy
295,298
+7,843
+3% +$1.82M 0.33% 70
2017
Q2 		$69.9M Buy
287,455
+6,722
+2% +$1.58M 0.39% 55
2017
Q1 		$67.1M Sell
280,733
-41,767
-13% -$9.73M 0.38% 55
2016
Q4 		$67.8M Buy
322,500
+6,306
+2% +$1.31M 0.4% 55
2016
Q3 		$75.2M Buy
316,194
+10,087
+3% +$2.46M 0.47% 47
2016
Q2 		$70.7M Buy
306,107
+80,911
+36% +$18.7M 0.48% 47
2016
Q1 		$60.4M Buy
225,196
+4,615
+2% +$1.32M 0.45% 49
2015
Q4 		$68.9M Buy
220,581
+1,977
+0.9% +$589K 0.52% 42
2015
Q3 		$59.4M Sell
218,604
-2,028
-0.9% -$623K 0.49% 43
2015
Q2 		$67M Buy
220,632
+11,818
+6% +$3.52M 0.47% 53
2015
Q1 		$62.1M Buy
208,814
+100,508
+93% +$28.7M 0.43% 55
2014
Q4 		$27.9M Sell
108,306
-426
-0.4% -$106K 0.22% 106
2014
Q3 		$26.2M Buy
108,732
+37,411
+52% +$8.37M 0.21% 110
2014
Q2 		$15.9M Sell
71,321
-550
-0.8% -$114K 0.12% 202
2014
Q1 		$14.8M Buy
71,871
+3,700
+5% +$733K 0.12% 199
2013
Q4 		$11.5M Buy
68,171
+17,789
+35% +$2.78M 0.1% 238
2013
Q3 		$7.25M Buy
50,382
+11,859
+31% +$1.58M 0.06% 323
2013
Q2 		$4.86M Buy
+38,523
New +$4.36M 0.05% 359

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Aviva's AGN Position: Q2 2020 in Review

Aviva sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 206,322 shares — an estimated $36.5M sold.

Aviva first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $75.2M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Aviva reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Aviva sold 206,322 Allergan plc shares in Q2 2020, an estimated $36.5M.
  • Aviva first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Aviva's Allergan plc position peaked at $75.2M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.